'Free' copper in serum of Alzheimer's disease patients correlates with markers of liver function

Journal of Neural Transmission

Volumn 114, Issue 12, 2007, Pages 1589-1594

  Squitti, R ^a,e   Ventriglia, M ^a   Barbati, G ^a   Cassetta, E ^a   Ferreri, F ^b   Dal Forno, G ^a,c   Ramires, S ^a   Zappasodi, F ^a,d   Rossini, P M ^a,b  

^a IRCCS ISTITUTO CENTRO SAN GIOVANNI DI DIO FATEBENEFRATELLI   (Italy)

^b UNIVERSITY CAMPUS BIO MEDICO   (Italy)

^c MEDICAL COLLEGE OF WISCONSIN   (United States)

^d INSTITUTE OF COGNITIVE SCIENCES AND TECHNOLOGIES   (Italy)

^e FATEBENEFRATELLI HOSPITAL   (Italy)

Author keywords

'Free' copper; Alzheimer's disease; Liver function

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; APOLIPOPROTEIN E; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; BIOLOGICAL MARKER; CERULOPLASMIN; CHOLESTEROL; COPPER; GAMMA GLUTAMYLTRANSFERASE; IRON; SERUM ALBUMIN;

AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALZHEIMER DISEASE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CHRONIC LIVER DISEASE; CONTROLLED STUDY; COPPER BLOOD LEVEL; COPPER METABOLISM; CORRELATION ANALYSIS; FEMALE; GENOTYPE; HUMAN; LIVER FUNCTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTHROMBIN TIME;

AGED; ALANINE TRANSAMINASE; ALBUMINS; ALZHEIMER DISEASE; APOLIPOPROTEIN E4; ASPARTATE AMINOTRANSFERASES; BILIRUBIN; CERULOPLASMIN; COPPER; FEMALE; GAMMA-GLUTAMYLTRANSFERASE; HUMANS; LIVER DISEASES; LIVER FUNCTION TESTS; MALE; MIDDLE AGED; PROTHROMBIN TIME;

EID: 36749090530     PISSN: 03009564     EISSN: 14351463     Source Type: Journal    
DOI: 10.1007/s00702-007-0777-6     Document Type: Article

References (47)

1. A Abe S Yamashita A Noma 1989 Sensitive, direct colorimetric assay for copper in serum Clin Chem 35 552 554
2. KJ Barnham WJ McKinstry G Multhaup D Galatis CJ Morton CC Curtain NA Williamson AR White MG Hinds RS Norton K Beyreuther CL Masters MW Parker R Cappai 2003 Structure of the Alzheimer's disease amyloid precursor protein copper binding domain. A regulator of neuronal copper homeostasis J Biol Chem 278 17401 17407
3. TA Bayer S Schafer A Simons A Kemmling T Kamer R Tepest A Eckert K Schussel O Eikenberg C Sturchler-Pierrat D Abramowski M Staufenbiel G Multhaup 2003 Dietary Cu stabilizes brain superoxide dismutase 1 activity and reduces amyloid A-beta production in APP23 transgenic mice Proc Natl Acad Sci USA 100 14187 14192
4. SA Bellingham GD Ciccotosto BE Needham LR Fodero AR White CL Masters R Cappai J Camakaris 2004a Gene knockout of amyloid precursor protein and amyloid precursor-like protein-2 increases cellular copper levels in primary mouse cortical neurons and embryonic fibroblasts J Neurochem 91 423 428
5. SA Bellingham DK Lahiri B Maloney S La Fontaine G Multhaup J Camakaris 2004b Copper depletion down-regulates expression of the Alzheimer's disease amyloid-beta precursor protein gene J Biol Chem 279 20378 20386
6. P Bielli L Calabrese 2002 Structure to function relationships in ceruloplasmin: a 'moonlighting' protein Cell Mol Life Sci 59 1413 1427
7. AS Botash J Nasca R Dubowy HL Weinberger M Oliphant 1992 Zinc-induced copper deficiency in an infant Am J Dis Child 146 709 711
8. JD Boyett HP Lehmann MF Beeler 1976 Automated assay of ceruloplasmin by kinetic analysis of o-dianisidine oxidation Clin Chim Acta 69 233 241
9. G Bucolo H David 1973 Quantitative determination of serum triglycerides by the use of enzymes Clin Chem 19 476
10. AI Bush 2003 The metallobiology of Alzheimer's disease Trends Neurosci 26 207 214
11. AI Bush 2004 Serum copper Arch Neurol 61 631 632
12. RM Corbo R Scacchi L Mureddu G Mulas G Alfano 1995 Apolipoprotein E polymorphism in Italy investigated in native plasma by a simple polyacrylamide gel isoelectric focusing technique. Comparison with frequency data of other European populations Ann Hum Genet 59 197 209
13. JP Correia PS Alves EA Camilo 1981 SGOT-SGPT ratios Dig Dis Sci 26 284
14. R Deeg J Ziegenhorn 1983 Kinetic enzymatic method for automated determination of total cholesterol in serum Clin Chem 29 1798 1802
15. BT Doumas HG Biggs 1972 Determination of serum albumin Standard Methods of clinical chemistry Academic Press New York 175
16. P Ferenci K Caca G Loudianos G Mieli-Vergani S Tanner I Sternlieb M Schilsky D Cox F Berr 2003 Diagnosis and phenotypic classification of Wilson disease Liver Int 23 139 142
17. MF Folstein SE Folstein PR McHugh 1975 "Mini-Mental State" a practical method for grading the cognitive state of patients for the clinician J Psych Res 12 189 198
18. C Gonzalez T Martin J Cacho MT Brenas T Arroyo B Garcia-Berrocal JA Navajo JM Gonzalez-Buitrago 1999 Serum zinc, copper, insulin and lipids in Alzheimer's disease epsilon 4 apolipoprotein E allele carriers Eur J Clin Invest 29 637 642
19. T Higgins 1981 Novel chromogen for serum iron determinations Clin Chem 27 1619
20. JE Hixson DT Vernier 1990 Restriction isotyping of human APOE by gene amplification and cleavage with HhaI J Lipid Res 31 545 548
21. T Hoogenraad 2001 Wilson's disease Intermed Medical Publishers Amsterdam, Rotterdam
22. A Hye S Lynham M Thambisetty M Causevic J Campbell HL Byers C Hooper F Rijsdijk SJ Tabrizi S Banner CE Shaw C Foy M Poppe N Archer G Hamilton J Powell RG Brown P Sham M Ward S Lovestone 2006 Proteome-based plasma biomarkers for Alzheimer's disease Brain 129 3042 3050
23. V Iyengar GJ Brewer RD Dick OY Chung 1988 Studies of cholecystokinin- stimulated biliary secretions reveal a high molecular weight copper-binding substance in normal subjects that is absent in patients with Wilson's disease J Lab Clin Med 111 267 274
24. H Kessler FG Pajonk P Meisser T Schneider-Axmann KH Hoffmann T Supprian W Herrmann R Obeid G Multhaup P Falkai TA Bayer 2006 Cerebrospinal fluid diagnostic markers correlate with lower plasma copper and ceruloplasmin in patients with Alzheimer's disease J Neural Transm 113 1763 1769
25. HP Lehmann KH Schosinsky MF Beeler 1974 Standardization of serum ceruloplasmin concentrations in international enzyme units with o-dianisidine dihydrochloride as substrate Clin Chem 20 1564 1567
26. MA Lovell JD Robertson WJ Teesdale JL Campbell WR Markesbery 1998 Copper, iron and zinc in Alzheimer's disease senile plaques J Neurol Sci 158 47 52
27. CJ Maynard R Cappai I Volitakis RA Cherny AR White K Beyreuther CL Masters AI Bush QX Li 2002 Overexpression of Alzheimer's disease amyloid-beta opposes the age-dependent elevations of brain copper and iron J Biol Chem 277 44670 44676
28. G McKhann D Drachman M Folstein R Katzman D Price EM Stadlan 1984 Clinic diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of the Department of Health and Human Services Task Force on Alzheimer's disease Neurology 34 939 944
29. MC Morris DA Evans CC Tangney JL Bienias JA Schneider RS Wilson PA Scherr 2006 Dietary copper and high saturated and trans fat intakes associated with cognitive decline Arch Neurol 63 1085 1088
30. RM Nalbandyan 1983 Copper in brain Neurochem Res 8 1211 1232
31. JP Persijn W van der Silk 1976 A new method for the determination of gamma-glutamyltransferase in serum J Clin Chem Clin Biochem 14 421 427
32. LM Sayre G Perry PL Harris Y Liu KA Schubert MA Smith 2000 In situ catalysis by neurofibrillary tangles and senile plaques in Alzheimer's disease: a central role for bound transition metals J Neurochem 74 270 279
33. IH Scheinberg I Sternlieb 1984 Wilson disease Saunders Philadelphia 25 37
34. KH Schosinsky HP Lehmann MF Beeler 1974 Measurement of ceruloplasmin from its oxidase activity in serum by use of o-dianisidine dihydrochloride Clin Chem 20 1556 1563
35. BS Skikne CH Flowers JD Cole 1990 Serum transferrin receptor, a quantitative measure of tissue iron deficiency Blood 75 1870 1876
36. MA Smith PL Harris LM Sayre G Perry 1997 Iron accumulation in Alzheimer disease is a source of redox-generated free radicals Proc Natl Acad Sci USA 94 9866 9868
37. J Snaedal J Kristinsson S Gunnarsdottir Olafsdotti M Baldvinsson T Johannesson 1998 Copper, ceruloplasmin and superoxide dismutase in patients with Alzheimer's disease. a case-control study Dement Geriatr Cogn Disord 9 239 242
38. R Squitti P Pasqualetti G Dal Forno F Moffa E Cassetta D Lupoi F Vernieri L Rossi M Baldassini PM Rossini 2005 Excess of serum copper not related to ceruloplasmin in Alzheimer disease Neurol 64 1040 1046
39. R Squitti G Barbati L Rossi M Ventriglia G Dal Forno S Cesaretti F Moffa I Caridi E Cassetta P Pasqualetti L Calabrese D Lupoi PM Rossini 2006a Excess of non ceruloplasmin serum copper in ad correlates with MMSE, CSF β-amyloid and H tau Neurology 67 76 82
40. Squitti R, Quattrocchi CC, Dal Forno G, Antuono P, Wekstein DR, Capo CR, Salustri C, Rossini PM (2006b) Ceruloplasmin (2-D PAGE) Pattern and Copper Content in Serum and Brain of Alzheimer Disease Patients. Biomarker Insights 2: 205-213 (http://www.la-press.com/biomark06.htm)
41. G Szasz 1974 New substrates for measuring gamma-glutamyl transpeptidase activity Z Klin Chem Klin Biochem 12 228
42. L Thomas 1998 Alanine aminotransferase (ALT), Aspartate aminotransferase (AST) L Thomas Clinical laboratory diagnostics 1 TH-Books Verlagsgesellschaft Frankfurt 55 65 192-202
43. P Trinder 1969 Determination of glucose in blood using glucose oxidase with an alternative oxygen acceptor Ann Clin Biochem 6 24
44. th Symposium of Wilson's disease. University Press, Delft, pp 21-28
45. JM Walshe 2003 Clinical Investigations Standing Committee of the Association of Clinical Biochemists. Wilson's disease: the importance of measuring serum caeruloplasmin non-immunologically Ann Clin Biochem 40 115 121
46. AR White R Reyes JF Mercer J Camakaris H Zheng AI Bush G Multhaup K Beyreuther CL Masters R Cappai 1999 Copper levels are increased in the cerebral cortex and liver of APP and APLP2 knockout mice Brain Res 842 439 444
47. PL Wolf 1982 Ceruloplasmin: methods and clinical use Crit Rev Clin Lab Sci 17 229 245